Infection, disease & health · 2025
Bacterial bloodstream infections in a pediatric population: A 7-year experience at a tertiary care center in Saudi Arabia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Basnawi Faten, Essa Ruba Abo, Alosaimi Aeshah, Alrshaid Bandar, Alshuhri Sabah, Almazrua Afnan, Alyabes Ohoud, Alsuhaibani Mohammed, Hussain Ibrahim Bin, Albanyan Esam, Alhajjar Sami, Aljumaah Suliman, Alghamdi Salem
Аннотация
OBJECTIVES: This study explored the epidemiological trends and antimicrobial susceptibility patterns of bloodstream pathogens among pediatric patients over a 7-year period at a tertiary care facility in Saudi Arabia.
METHODS: This retrospective single-center longitudinal descriptive study was conducted from 2015 to 2021. Blood culture and susceptibility data of pathogens isolated from patients aged <15 years were extracted from the hospital's laboratory information system. The trends observed over the 7-year period were graphically illustrated.
RESULTS: Among the 83,605 pediatric blood cultures analyzed, 2945 (3.5 %) tested positive. Approximately 65 % of the positive cultures were confirmed as true bloodstream infections (BSIs), with an average BSI rate of 3 per 1000 inpatient days. Gram-negative bacterial infections accounted for 61 % of BSIs, with Klebsiella spp. being the most prevalent. Susceptibility testing revealed reduced sensitivity to meropenem, imipenem, ciprofloxacin, and levofloxacin among gram-negative bacteria. Gram-positive pathogens represented 39 % of infections, with the most common being Staphylococcus spp. (21 %) and Streptococcus spp. (7 %). Methicillin-resistant Staphylococcus aureus exhibited 100 % sensitivity to vancomycin, quinupristin/dalfopristin, tigecycline, and linezolid. However, Streptococcus pneumoniae showed decreasing sensitivity to penicillin and ceftriaxone for meningitis (33 % and 55 % susceptibility, respectively). Furthermore, Enterococcus spp. were less susceptible against ampicillin, linezolid, levofloxacin, and vancomycin.
CONCLUSIONS: The findings of this study offer crucial insights into the incidence of pediatric bacteremia and trends in antibiotic susceptibility, which can inform treatment strategies, guide antibiotic stewardship programs, and enhance infection control measures in healthcare settings.
METHODS: This retrospective single-center longitudinal descriptive study was conducted from 2015 to 2021. Blood culture and susceptibility data of pathogens isolated from patients aged <15 years were extracted from the hospital's laboratory information system. The trends observed over the 7-year period were graphically illustrated.
RESULTS: Among the 83,605 pediatric blood cultures analyzed, 2945 (3.5 %) tested positive. Approximately 65 % of the positive cultures were confirmed as true bloodstream infections (BSIs), with an average BSI rate of 3 per 1000 inpatient days. Gram-negative bacterial infections accounted for 61 % of BSIs, with Klebsiella spp. being the most prevalent. Susceptibility testing revealed reduced sensitivity to meropenem, imipenem, ciprofloxacin, and levofloxacin among gram-negative bacteria. Gram-positive pathogens represented 39 % of infections, with the most common being Staphylococcus spp. (21 %) and Streptococcus spp. (7 %). Methicillin-resistant Staphylococcus aureus exhibited 100 % sensitivity to vancomycin, quinupristin/dalfopristin, tigecycline, and linezolid. However, Streptococcus pneumoniae showed decreasing sensitivity to penicillin and ceftriaxone for meningitis (33 % and 55 % susceptibility, respectively). Furthermore, Enterococcus spp. were less susceptible against ampicillin, linezolid, levofloxacin, and vancomycin.
CONCLUSIONS: The findings of this study offer crucial insights into the incidence of pediatric bacteremia and trends in antibiotic susceptibility, which can inform treatment strategies, guide antibiotic stewardship programs, and enhance infection control measures in healthcare settings.